Mike YW Kwan, MRCPCH, MSc (Applied Epidemiology CUHK) 2 1 Department of Paediatrics and Adolescent Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong 2 Department of Paediatrics and Adolescent Medicine, Princess Margaret Hospital, Hong Kong 3 Haematology Laboratory, Department of Pathology, Princess Margaret Hospital, Hong Kong 4 Division of Chemical Pathology, Department of Pathology, Queen Mary Hospital, Hong Kong 5 Department of Pathology, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong 6 Division of Transplantation and Immunogenetics, Department of Pathology, Queen Mary Hospital, Hong Kong 7 Division of Clinical Immunology, Department of Pathology, Queen Mary Hospital, Hong Kong 8 Division of Dermatology, Department of Medicine, Queen Mary Hospital, Hong Kong 9 Department of Ophthalmology and Visual Sciences, Chinese University of Hong Kong, Hong Kong 10 Department of Microbiology, Carol Yu Centre for Infection, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong 11 Division of Paediatric Surgery, Department of Surgery, The University of Hong Kong, Hong Kong 12 Dr Li Dak-Sum Research Centre, The University of Hong KongKarolinska Institutet Collaboration in Regenerative Medicine, The University of Hong Kong, Hong Kong 13 Department of Paediatric Infectious Diseases, Great Ormond Street Hospital for Children, London, United Kingdom 14 Institute of Child Health, University College London, London, United Kingdom 15 Section of Paediatrics, Imperial College London, London, United Kingdom 16 Paediatric Infectious Diseases Department, Imperial College Healthcare NHS Trust, London, United Kingdom Co-first authors Corresponding author: Dr Mike YW Kwan ( [email protected] ) Case report A 10-year-old ethnic-Russian boy was confirmed to have severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) during the second wave of the coronavirus disease 2019 (COVID-19) outbreak in Hong Kong.1 He had a past medical history of coarctation of the aorta with corrective surgery performed at age 2 months
Balancing the benefits and harms In hospitalized individuals with elevated blood glucose levels, basal-bolus insulin therapy is preferred over sliding-scale insulin due to its superior glycemic control and its ability to reduce blood glucose-related outcomes and hospitalization-associated complications, although appropriate monitoring is necessary
Tyler Sadwith, chief deputy director of DHCS
Timing of GLP-1 receptor agonist initiation for treatment of type 2 diabetes in the UK
24 The device hurdle: Injectors vs
